In addition, this paper also utilizes DEA assessment system to evaluate the performance of the listed pharmaceutical companies.
此外，本文还运用了DEA模型进行了医药上市公司的业绩评价的实证分析。
The second part analysis the theoretical on ownership structure and corporate performance in Chinese Bio-Pharmaceutical listed companies.
第二部分对我国上市公司股权结构与公司绩效进行理论分析。
This article tries to make a more systematic research on the capital structure of listed companies in this specific context of the pharmaceutical industry.
本文就是在此特定背景下对我国制药行业上市公司资本结构影响因素进行较为系统地研究。
应用推荐